N/A
Completed N=40
Citicoline, Creatine, and Omega-3 Effects in Middle Age Women
Cognitive Benefits
Source: ClinicalTrials.gov NCT01502813 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcomePrimary: Change From Baseline in California Verbal Learning Test (CVLT) That Measure Attention and Memory at 14 Days — 10 score on a scale
Summary
The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiatric adult female participants.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in California Verbal Learning Test (CVLT) That Measure Attention and Memory at 14 Days |
10 | — |
| PRIMARY Change From Baseline in WAIS-IV Block Design Subtest A That Measures Attention and Memory at 28 Days |
98 | — |
Eligibility Criteria
Inclusion Criteria
- Female
- Age 40-60 years
Exclusion Criteria
- Significant medical condition
- History of co-morbid psychiatric disorders
- Current Axis I or II diagnosis
- Past participation in a pharmacotherapeutic trial
- Head injury with LOC>5 minutes
- Use of psychotropic medication
- History of fish allergies
- Medical condition associated with clinically significant decreases in coagulability
- Use of anticoagulant medication
Data sourced from ClinicalTrials.gov (NCT01502813). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.